REFCON is introduced, a deep-learning model that enables reference-free copy number profiling from scRNA-seq data collected without matched normals, and profiles pure tumors, generalizes to unseen tissues and platforms, and stays robust to cohort composition.
Abstract
Single-cell RNA sequencing (scRNA-seq) is widely used to infer copy number profiles from tumor cells. Existing methods build on a reference-based normalization paradigm: normalizing each tumor cell against a reference of normal cells, whether supplied, in-sample, or synthesized. This makes them reference-dependent and as a result, sensitive to cohort composition, and prone to false positives. To address these limitations, we introduce REFCON, a deep-learning model that enables reference-free copy number profiling from scRNA-seq data. REFCON estimates local copy-number deviations and jointly optimizes them into a genome-wide per-cell profile. It profiles pure tumors, generalizes to unseen tissues and platforms, and stays robust to cohort composition. Predicted copy number profiles distinguish malignant cells with high specificity, producing far fewer false-positive calls, and improve clonal reconstruction. The model can also benefit from reference cells when available, turning a field requirement into an optional refinement. Hence, REFCON extends reliable per-cell copy number profiling to the scRNA-seq data collected without matched normals.
Malva is presented, a computational platform that enables ultrafast, species-agnostic and reference-free interrogation of the raw sequence space, enabling searching for any sequence, mutation, splice junction or pathogen, or spatial location of arbitrary transcripts.
D. León-Periñán, Nikos Karaiskos, N. Rajewsky· Nature· 1 citation
This work introduces a two-stage statistical framework for interpretable patient-level disease classification from single-cell data, and recovered biologically coherent, cell-type specific gene signatures consistent with known disease mechanisms, demonstrating improved interpretability without sacrificing predictive ac...
Zhi-Wei Xiao, William Torous, Jeffrey B. Cheng et al.· bioRxiv· 0 citations
DeepCelllify is introduced, a novel deep learning-based framework that harnesses convolutional neural networks (CNNs) to classify patients using their individual cell expression profiles, and demonstrates competitive performance compared to state-of-the-art approaches.
A. Oulas, N. Karathanasis, T. Lampadarios et al.· Frontiers in Bioinformatics· 0 citations
Unsupervised read-level differential analysis recovers established lncRNA biomarkers; uncovers new prognostic transposable-element reads in adrenocortical carcinoma and sarcomas; and extracts signals even from reads that fail to align.
Erkan Narmanli, Alexandre Lanau, Mara Neacsu et al.· bioRxiv· 0 citations
Summary Single-sample transcriptomic analysis can provide gene-level views of how individual tumors deviate from matched reference states, complementing cohort-level differential expression. Here, we present HopRatio, a rank-based framework that quantifies, for each gene in each sample, the fraction of stable reference...
Yue Zhao, Bo Gao, Rui-Zhong Chen· iScience· 0 citations
To enable evaluation of normalization methods for identification of coregulation, 35 scRNA-seq samples with known regulature relationships are curated and preprocessed into a catalog and results indicate implementation choices for advanced normalization methods.
Valentine Svensson· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.